Pirabel during prolonged physical work and recovery — monograph section 6.2
S. V. Okovityi, E. B. Shustov, V. Ts. Bolotova · 2019 · Work Capacity, Fatigue, Correction. Knorus; section 6.2, pp. 184–189
What does this source report?
The book describes a double-blind comparison including placebo, Bemitil, and Pirabel, with performance and recovery measures. It reports endpoint-specific differences, not universal improvement.
- Population and setting
- 78 healthy volunteers aged 18–25, divided into eight groups; six-hour physical-load model
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Group allocation is described as equivalent groups; randomization has not been established.
- No piracetam-only group appears in the listed comparison, so this cannot establish pharmacological synergy.
- A monograph report is not independent replication; original cited reports require retrieval.
- Young volunteers performing controlled physical work do not establish effects on sleep, watchkeeping, or toxic-exposure safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Recovered monograph section
Review depth: Section 6.2; allocation appraisal incomplete
Related-report group: pirabel-78-volunteer-programme. Reports in this group are not assumed to be independent trials.
Source access and review scope
Recovered 330-page attachment: title page and section text checked; page 184 visually inspected. Full independent methods review not completed.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: S. V. Okovityi, E. B. Shustov, V. Ts. Bolotova. Pirabel during prolonged physical work and recovery — monograph section 6.2 Work Capacity, Fatigue, Correction. Knorus; section 6.2, pp. 184–189 2019.
Molekul research summary: https://molekul.io/research/pirabel-fatigue-2019. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Pirabel
The piracetam–Bemitil combination discussed in the 2019 fatigue monograph and earlier dissertation trail. The monograph attachment has been recovered; methods appraisal and independent replication remain pending.
Piracetam
Piracetam, marketed as Nootropil, connects the original nootropic concept with Soviet clinical adoption and later operator, hypoxia and maritime research. Healthy-volunteer experiments, clinical reviews and combination proposals answer different questions.
Bemitil
A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.